Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Sensipar

Generic name: Cinacalcet

FDA application holder: Amgen

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Sensipar?
Sensipar is a brand name of Cinacalcet, a prescription medicine. The FDA NDC Directory lists 3 Sensipar products in 3 strengths and forms.
Who makes Sensipar?
Amgen holds the FDA application for Sensipar (NDA021688, approved March 8, 2004).
Is there a generic or store brand of Sensipar?
Other products of Cinacalcet are listed with the FDA, but none in exactly the same strength and form as a Sensipar product.
Has Sensipar been recalled?
FDA enforcement reports list 3 recalls of Sensipar products; the newest started June 4, 2026. A recall usually concerns specific lots, not every product.

What Sensipar is

Each Sensipar product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Cinacalcet · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
cinacalcet hydrochloride 30 mg
tablet, coated (oral)
Sensipar None listed DailyMed
cinacalcet hydrochloride 60 mg
tablet, coated (oral)
Sensipar None listed DailyMed
cinacalcet hydrochloride 90 mg
tablet, coated (oral)
Sensipar None listed DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Cinacalcet →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Sensipar products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA021688AmgenMarch 8, 20043

Companies that list Sensipar

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Sensipar products.

Recalls

From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.

  1. June 4, 2026 · Class II · Ongoing · D-0616-2026

    CGMP Deviations

    Sensipar (cinacalcet) Tablets, 90mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks, CA 91320-1799, Made in Japan. NDC 55513-075-30 — Amgen, Inc.

  2. June 4, 2026 · Class II · Ongoing · D-0614-2026

    CGMP Deviations

    Sensipar (cinacalcet) Tablets, 60mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks ,CA 91320-1799, Made in Japan. NDC 55513-074-30 — Amgen, Inc.

  3. June 4, 2026 · Class II · Ongoing · D-0613-2026

    CGMP Deviations

    Sensipar (cinacalcet) Tablets, 30mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks ,CA 91320-1799, Made in Japan. NDC 55513-073-30 — Amgen, Inc.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers